Phone (Mobile)
+1 484 ❅❅❅ ❅❅❅❅
Phone (Mobile)
Phone (HQ)
(484) 879-4284
Phone (HQ)
❅❅❅❅❅@spherixglobalinsights.com
Office Address (HQ)
760 Constitution Dr Ste 204, Exton, Pennsylvania, 19341, United States
Office Address (HQ)
Get 10 Free Leads on us
Use our Chrome Extension & instantly connect with prospects
Meghan Staudt
According to Datanyze information, these are Meghan Staudt's contact details. Reveal the hidden information below for FREE!
Phone (Mobile)
+1 484 ❅❅❅ ❅❅❅❅
Phone (Mobile)
Phone (HQ)
(484) 879-4284
Phone (HQ)
❅❅❅❅❅@spherixglobalinsights.com
Office Address (HQ)
760 Constitution Dr Ste 204, Exton, Pennsylvania, 19341, United States
Office Address (HQ)
Meghan Staudt works as a Director, Insights, Nephrology at Spherix Global Insights, which is an Advertising & Marketing company with an estimated 35 employees; and founded in 2015. They are part of the Medicine team within the Medical & Health Department and their management level is Director. Meghan is currently based in Exton, United States. They used to work at TRC Insights and Geisinger Medical Laboratories and have used the following emails: @spherixglobalinsights.com, @trchome.com.
Quickly connect with Meghan before someone else does! 👏
Meghan Staudt's career began less then a year ago. Prior to joining Spherix Global Insights, Meghan worked at 3 companies.
Hostess
Research Associate & Manager
Conference Center Intern
Spherix Global Insights
760 Constitution Dr Ste 204, Exton, Pennsylvania, 19341, United States
35
$15.4 M
Advertising & Marketing, Business Services
Get Full Profile Access
Ice Breakers
Imagine you could know all about Spherix Global Insights - Meghan Staudt’s company, before you contact them. Warm up a cold prospect with Datanyze icebreakers
Meghan’s company in the news
New American College of Rheumatology Guidelines for Lupus Nephritis Recommend Triple Therapy, Highlighting a Shift in Current Treatment Practices, According to Spherix Global Insights
January 8, 2025
Inflation Reduction Act Likely to Shape Specialty Prescribing Decisions in 2025, According to Spherix Global Insights
December 10, 2024
Patient Chart Audit Reveals Changing Paroxysmal Nocturnal Hemoglobinuria (PNH) Market Dynamics As New Competition Challenges Alexion/Astra Zeneca's Soliris and Ultomiris
November 21, 2024
See more
Insights to Break the Ice
In your first interaction
Meghan’s CEO is Dan Barton
Meghan is located in United States
Work Colleague
See Meghan Staudt's coworkers out of Spherix Global Insights's 35 employees